Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Paradeep Phosphates IPO and Rainbow Children Medicare IPO.
Paradeep Phosphates IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Rainbow Children Medicare IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| Paradeep Phosphates IPO | Rainbow Children Medicare IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Axis Capital Limited ICICI Securities Limited Jm Financial Limited SBI Capital Markets Limited |
Kotak Mahindra Capital Company Limited J.P. Morgan India Private Limited Iifl Securities Ltd |
| Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | Anchor Investor |
|
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of Paradeep Phosphates IPO is up to ₹1,501.73 Cr whereas the issue size of the Rainbow Children Medicare IPO is up to ₹1,580.85 Cr. The final issue price of Paradeep Phosphates IPO is ₹42.00 per share and of Rainbow Children Medicare IPO is ₹542.00 per share.
| Paradeep Phosphates IPO | Rainbow Children Medicare IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹39.00 per share | ₹516.00 per share |
| Issue Price (Upper) | ₹42.00 per share | ₹542.00 per share |
| Issue Price (Final) | ₹42.00 per share | ₹542.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹20.00 per share | |
| Market Lot Size | 350 shares | 27 shares |
| Fresh Issue Size | 23,90,47,619 shares | |
| Fresh Issue Size (Amount) | up to ₹1,004.00 Cr | up to ₹280.00 Cr |
| OFS Issue Size | 11,85,07,493 shares | 2,40,00,900 shares |
| OFS Issue Size (Amount) | up to ₹497.73 Cr | up to ₹1,300.85 Cr |
| Issue Size Total | 35,75,55,112 shares | |
| Issue Size Total (Amount) | up to ₹1,501.73 Cr | up to ₹1,580.85 Cr |
Paradeep Phosphates IPO opens on May 17, 2022, while Rainbow Children Medicare IPO opens on Apr 27, 2022. The closing date of Paradeep Phosphates IPO and Rainbow Children Medicare IPO is May 19, 2022, and Apr 29, 2022, respectively.
| Paradeep Phosphates IPO | Rainbow Children Medicare IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 17, 2022 | Apr 27, 2022 |
| Issue Close | May 19, 2022 | Apr 29, 2022 |
| Basis Of Allotment (Tentative) | May 24, 2022 | May 05, 2022 |
| Initiation of Refunds (Tentative) | May 25, 2022 | May 06, 2022 |
| Credit of Share (Tentative) | May 26, 2022 | May 09, 2022 |
| Listing date (Tentative) | May 27, 2022 | May 10, 2022 |
| Anchor Lockin End date 1 | Jun 23, 2022 | Jun 04, 2022 |
| Anchor Lockin End date 2 | Aug 22, 2022 | Aug 03, 2022 |
Paradeep Phosphates IPO P/E ratio is 7.07, as compared to Rainbow Children Medicare IPO P/E ratio of 43.53.
| Paradeep Phosphates IPO | Rainbow Children Medicare IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100% | 62.19% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 49.83% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 7.07 | 43.53 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹3420.89 Cr. | ₹5501.30 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Paradeep Phosphates IPO retail investors (RII) are offered 13,15,80,187 shares while in Rainbow Children Medicare IPO retail investors are offered 13,15,80,187 shares. Qualified institutional buyers (QIB) are offered 8,07,05,162 shares in Paradeep Phosphates IPO and 1,44,33,000 shares in Rainbow Children Medicare IPO.
| Paradeep Phosphates IPO | Rainbow Children Medicare IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 8,07,05,162 shares | 1,44,33,000 shares |
| NII | 5,63,91,509 shares | 43,30,000 shares |
| RII | 13,15,80,187 shares | 1,01,03,000 shares |
| Employee | 3,00,000 shares | |
| Others | ||
| Total | 26,86,76,858 shares | 2,88,66,000 shares |
Paradeep Phosphates IPO subscribed 1.75x in total, whereas Rainbow Children Medicare IPO subscribed 12.43x.
| Paradeep Phosphates IPO | Rainbow Children Medicare IPO | |
|---|---|---|
| QIB (times) | 3.01x | 38.90x |
| NII (times) | 0.82x | 3.73x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.37x | 1.38x |
| Employee (times) | 0.31x | |
| Other (times) | ||
| Total (times) | 1.75x | 12.43x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
